scorecardresearchCipla Share Price Live NSE, BSE, Today - Cipla Stock Price

Cipla

BSE: 500087 | NSE: CIPLA | ISIN: INE059A01026 | SECTOR: Biotechnology & Drugs

1,189.75 25.75 (2.21%)

29 Sep 2023, 09:59 (IST)
  • Open

    1,167.00
  • High

    1,199.00
  • Low

    1,166.10
  • Prev Close

    1,164.00
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    960.51B
  • Volume

    32.11K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    -

Company Description

  • Biotechnology & Drugs
  • BSE

    500087
  • NSE

    CIPLA
  • ISIN

    INE059A01026

Cipla Limited is an India-based company, which is primarily engaged in the business of pharmaceuticals. The Company operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. The Company's product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, the United States, South Africa, and Rest of the World. The Company has its network of manufacturing, trading and other incidental operations in India and International markets. The Company has approximately 47 manufacturing sites.

Company Officers

  • Umang Vohra

    Global Chief Executive Officer, Managing Director, Executive Director
  • Samina Hamied

    Executive Vice Chairman of the Board
  • Ashish Adukia

    Global Chief Financial Officer
  • Achin Gupta

    Chief Executive Officer - One India Business
  • Paul Miller

    Chief Executive Officer - Cipla South Africa and Regional Head Africa and Access
  • Nishant Saxena

    Chief Executive Officer - Emerging Markets and Europe
  • Arunesh Verma

    Chief Executive Officer - North America
  • Geena Malhotra

    Global Chief Technology Officer
  • Pradeep Bhadauria

    Global Chief Scientific Officer
  • Rajendra Chopra

    Compliance Officer, Company Secretary